JP7402804B2 - ピラゾール化合物及びその調製 - Google Patents

ピラゾール化合物及びその調製 Download PDF

Info

Publication number
JP7402804B2
JP7402804B2 JP2020541983A JP2020541983A JP7402804B2 JP 7402804 B2 JP7402804 B2 JP 7402804B2 JP 2020541983 A JP2020541983 A JP 2020541983A JP 2020541983 A JP2020541983 A JP 2020541983A JP 7402804 B2 JP7402804 B2 JP 7402804B2
Authority
JP
Japan
Prior art keywords
formula
compound
methyl
alkyl
difluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020541983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512127A5 (cg-RX-API-DMAC7.html
JP2021512127A (ja
Inventor
スニル・シャルマ
ディネシュ・ジャンギド
プリヤンカー・ダッカ
シッダート・マドワル
バラト・クマール
カピル・クマール
ラジープ・アナンド
アヌラグ・ジャイン
Original Assignee
マイオカーディア,インク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マイオカーディア,インク filed Critical マイオカーディア,インク
Publication of JP2021512127A publication Critical patent/JP2021512127A/ja
Publication of JP2021512127A5 publication Critical patent/JP2021512127A5/ja
Application granted granted Critical
Publication of JP7402804B2 publication Critical patent/JP7402804B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/72—Copper
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/06—Halogens; Compounds thereof
    • B01J27/08—Halides
    • B01J27/122—Halides of copper
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP2020541983A 2018-02-01 2019-02-01 ピラゾール化合物及びその調製 Active JP7402804B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IN201811003855 2018-02-01
IN201811003859 2018-02-01
IN201811003859 2018-02-01
IN201811003855 2018-02-01
IN201711042921 2018-05-30
IN201711042921 2018-05-30
PCT/IN2019/050076 WO2019150392A1 (en) 2018-02-01 2019-02-01 Pyrazole compounds and preparation thereof

Publications (3)

Publication Number Publication Date
JP2021512127A JP2021512127A (ja) 2021-05-13
JP2021512127A5 JP2021512127A5 (cg-RX-API-DMAC7.html) 2022-01-27
JP7402804B2 true JP7402804B2 (ja) 2023-12-21

Family

ID=67478207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020541983A Active JP7402804B2 (ja) 2018-02-01 2019-02-01 ピラゾール化合物及びその調製

Country Status (14)

Country Link
US (1) US11873289B2 (cg-RX-API-DMAC7.html)
EP (1) EP3746434A4 (cg-RX-API-DMAC7.html)
JP (1) JP7402804B2 (cg-RX-API-DMAC7.html)
KR (1) KR102951622B1 (cg-RX-API-DMAC7.html)
CN (1) CN111670184B (cg-RX-API-DMAC7.html)
AU (1) AU2019213854C1 (cg-RX-API-DMAC7.html)
BR (1) BR112020015692A2 (cg-RX-API-DMAC7.html)
CA (1) CA3090204A1 (cg-RX-API-DMAC7.html)
IL (1) IL276410B2 (cg-RX-API-DMAC7.html)
MA (1) MA54677A (cg-RX-API-DMAC7.html)
MX (2) MX2020008151A (cg-RX-API-DMAC7.html)
MY (1) MY209060A (cg-RX-API-DMAC7.html)
SG (1) SG11202007328UA (cg-RX-API-DMAC7.html)
WO (1) WO2019150392A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA54677A (fr) 2018-02-01 2021-11-17 Myokardia Inc Composés pyrazoles et leur préparation
WO2025244956A1 (en) * 2024-05-20 2025-11-27 MyoKardia, Inc. Methods of manufacturing danicamtiv

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007284386A (ja) 2006-04-18 2007-11-01 Kumiai Chem Ind Co Ltd 3−ピラゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤
WO2012166415A1 (en) 2011-05-27 2012-12-06 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
WO2016118774A1 (en) 2015-01-22 2016-07-28 MyoKardia, Inc. 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
WO2018132372A1 (en) 2017-01-10 2018-07-19 Sanford Burnham Prebys Medical Discovery Institute Small molecule activators of nicotinamide phosphoribosyltransferase (nampt) and uses thereof
WO2018191283A1 (en) 2017-04-11 2018-10-18 Oric Pharmaceuticals, Inc. Glucocorticoid receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8324178B2 (en) 2008-10-31 2012-12-04 The Regents Of The University Of California Method of treatment using alpha-1-adrenergic agonist compounds
CN104703972B (zh) 2012-08-30 2017-05-31 拜耳农作物科学股份公司 3,5‑双(卤烷基)‑吡唑‑4‑甲酸衍生物的脱羧方法
WO2014089913A1 (zh) 2012-12-12 2014-06-19 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的并环化合物
EP3063134B1 (en) 2013-11-01 2020-08-12 Srf Limited Process for the preparation of pyrazole derivatives
EP3015458A1 (en) 2014-11-03 2016-05-04 Bayer CropScience AG Process for preparing 3,5-bis(haloalkyl)pyrazole derivatives from a,a-dihaloamines and ketimines
MA54677A (fr) 2018-02-01 2021-11-17 Myokardia Inc Composés pyrazoles et leur préparation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007284386A (ja) 2006-04-18 2007-11-01 Kumiai Chem Ind Co Ltd 3−ピラゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤
WO2012166415A1 (en) 2011-05-27 2012-12-06 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
WO2016118774A1 (en) 2015-01-22 2016-07-28 MyoKardia, Inc. 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
WO2018132372A1 (en) 2017-01-10 2018-07-19 Sanford Burnham Prebys Medical Discovery Institute Small molecule activators of nicotinamide phosphoribosyltransferase (nampt) and uses thereof
WO2018191283A1 (en) 2017-04-11 2018-10-18 Oric Pharmaceuticals, Inc. Glucocorticoid receptor modulators

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
REGISTRY(STN)[online],検索日2023年1月16日:2010年 3月19日RN:1211751-27-7
REGISTRY(STN)[online],検索日2023年1月16日:2017年 7月27日RN:2104044-77-9, 2017年 7月27日RN:2104044-77-9, 2013年12月18日RN:1497942-42-3, 2013年12月12日RN:1493355-09-1, 2013年11月29日RN:1483601-89-3, 2013年11月26日RN:1481670-85-2, 2013年11月24日RN:1479559-89-1, 2013年11月 3日RN:1468599-50-9, 2013年10月30日RN:1465992-88-4, 2013年10月28日RN:1465207-27-5, 2012年 3月15日RN:1361004-09-2, 2011年11月10日RN:1343840-74-3, 2011年11月 8日RN:1342785-14-1,
REGISTRY(STN)[online],検索日2023年5月8日:2016年 1月31日RN:1856047-69-2

Also Published As

Publication number Publication date
EP3746434A4 (en) 2021-11-17
CA3090204A1 (en) 2019-08-08
IL276410B2 (en) 2024-09-01
IL276410B1 (en) 2024-05-01
MX2025003379A (es) 2025-05-02
MY209060A (en) 2025-06-18
JP2021512127A (ja) 2021-05-13
BR112020015692A2 (pt) 2020-12-08
AU2019213854C1 (en) 2023-12-14
US20210053940A1 (en) 2021-02-25
SG11202007328UA (en) 2020-08-28
KR102951622B1 (ko) 2026-04-13
AU2019213854A1 (en) 2020-09-03
CN111670184B (zh) 2026-07-10
MA54677A (fr) 2021-11-17
IL276410A (en) 2020-09-30
CN111670184A (zh) 2020-09-15
MX2020008151A (es) 2020-09-18
KR20200118025A (ko) 2020-10-14
AU2019213854B2 (en) 2023-06-15
WO2019150392A1 (en) 2019-08-08
US11873289B2 (en) 2024-01-16
EP3746434A1 (en) 2020-12-09

Similar Documents

Publication Publication Date Title
TWI663160B (zh) 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
CN101321522B (zh) 环氧丁醇中间体的制备方法
RU2539578C1 (ru) Способ получения 4-амино-3-хлор-5-фтор-6-(замещенных)пиколинатов
JP6275881B2 (ja) デュオカルマイシンのプロドラッグを製造するための改良された方法
IL301897A (en) Preparation processes of 3-FLUORO-5-(((1S,2AR)-1,3,3,4,4-PENTAFLUORO-2A-HYDROXY-2,2A,3,4-TETRAHYDRO-1H-CYCLOPENTA[CD]INDEN -7-YL)OXY)-benzonitrile
KR102951622B1 (ko) 피라졸 화합물 및 그의 제조
JP4330836B2 (ja) ピペラジン誘導体の製造方法
JP3662761B2 (ja) フェノキシアルキルハライド誘導体の新規製造法
JP2012111745A (ja) 5−トリフルオロメチル−4−ニトロ−2−イソキサゾリン化合物およびその製造方法
HK40027579A (en) Pyrazole compounds and preparation thereof
EA044890B1 (ru) Пиразольные соединения и их получение
JP2003335735A (ja) パーフルオロイソプロピルアニリン類の製造方法
JP2021512127A5 (cg-RX-API-DMAC7.html)
WO2006046417A1 (ja) 3,3,3-トリフルオロプロピオン酸の製造方法
JPWO1999038828A1 (ja) ブタントリオール誘導体の製造法
JP2619189B2 (ja) フタルイミド化合物およびその製造方法
JP2000226368A (ja) ジフルオロアセトフェノン誘導体の製造法
JP2001506255A (ja) チアゾール類の製造
JP2004115476A (ja) (r)−3−ハロゲノ−2−メチルプロパノールの製造方法
WO2011065351A1 (ja) シクロヘキサン誘導体の製造方法
KR20070090937A (ko) 2-(피라졸-1-일)피리딘 유도체
JPWO1992013854A1 (ja) フタルイミド化合物およびその製造方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220119

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230516

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230814

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230904

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231121

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231211

R150 Certificate of patent or registration of utility model

Ref document number: 7402804

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150